Antigen cross-presentation of immune complexes
The ability of dendritic cells (DC) to cross-present tumor antigens has long been a focus of interest of physicians, as well as basic scientists, that aim to establish efficient cell-based cancer immune therapy. A prerequisite for exploiting this pathway for therapeutic purposes is a better understa...
Main Authors: | Barbara ePlatzer, Madeleine Monique Stout, Edda eFiebiger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00140/full |
Similar Items
-
The role of FcRn in antigen presentation
by: Kristi eBaker, et al.
Published: (2014-08-01) -
Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination
by: Tyler W. Hulett, et al.
Published: (2018-04-01) -
The known unknowns of the human dendritic cell network
by: Mélanie eDurand, et al.
Published: (2015-03-01) -
Perspective view of allogeneic IgG tumor immunotherapy
by: Ying Liu, et al.
Published: (2024-03-01) -
Understanding the biology of antigen cross-presentation for the design of vaccines against cancer
by: Cynthia M. Fehres, et al.
Published: (2014-04-01)